In particular, Kirchberger et al. identified a role for IL23 driven IL22 producing ILC in bacteria-induced colitis-associated cancer in T and B cell deficient mice infected with H. hepaticus long-term or co-treated with 2-azoxymethane (a cancer inducing agent) (101). Here, CCL27 is linked to colitis.